Raloxifene (Evista), a new "designer estrogen"

July 1997

Lots of women are asking about raloxifene (Evista), a new "designer estrogen." It's been on the Today show, CNN, etc.

Lilly is testing raloxifene to prevent osteoporosis in postmenopausal women...as an alternative to using estrogen.

Raloxifene is actually similar to tamoxifen (Nolvadex).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New recommendations for preventing bacterial endocarditis
Lyme Disease Ceftin (cefuroxime) for Lyme disease
Lyme Disease Vaccine to prevent Lyme disease
Asthma New OTC device called Doser
Diabetes New recommendations for DIAGNOSING diabetes
Diabetes New guidelines for TREATING type 2 diabetes
Women's Health Raloxifene (Evista), a new "designer estrogen"
Women's Health Risks and benefits of hormone replacement therapy
Laxatives The stimulant laxative phenolphthalein will probably be taken off the market
New HIV protease inhibitors might increase blood sugar
New guidelines for treating HIV
Info about vaccines and medicines needed for international travel
What to use to prevent motion sickness
Loading up on creatine to boost performance
Pyruvate to enhance fat loss and improve endurance
Anticoagulants Two new anticoagulants just hit the market
Anticoagulants Orgaran (danaparoid) contains a substance that's similar to heparin...Heparan
Chronotherapeutics is a hot area right now